Summary
The product Injectable Anadrol 50mg, manufactured by Olympian Pharmaceutical, underwent independent testing to verify its authenticity and potency. The sample, identified by batch number 0069, was submitted by Olympian Pharmaceutical and analyzed by Janoshik Analytical, a laboratory specializing in pharmaceutical quality control. The analysis detected the presence of Oxymetholone, with a measured concentration of 47.23 mg/ml, which is 5.54% below the labeled claim of 50 mg/ml.
The testing process began on 24 October 2024, with the sample received on 30 October 2024, and analysis completed on 1 November 2024. While the results confirm a relatively accurate dosing, the slight underdosing highlights the need for continued scrutiny of manufacturer-submitted samples. Independent third-party testing is recommended to validate these findings across multiple batches. This report serves as an educational resource to promote harm reduction and informed decision-making.
Detailed Report
Product Overview
- Manufacturer: Olympian Pharmaceutical
- Product Name: Injectable Anadrol 50mg
- Active Ingredient: Oxymetholone
- Batch Number: 0069
- Expiration Date: Not provided
- Delivery Method: Injectable
Sample Acquisition and Testing
- Task Number: #51792
- Testing Ordered: 24 October 2024
- Sample Received: 30 October 2024
- Analysis Conducted By: Janoshik Analytical
- Product Submitted By: Olympian Pharmaceutical (Manufacturer)
- Analysis Paid For By: Olympian Pharmaceutical (Manufacturer)
Testing Results
- Specification: 50 mg/ml (as stated on the label)
- Measured Concentration: 47.23 mg/ml
- Accuracy: 94.46% (5.54% below the label claim)
Verification Details
Verification URL: https://janoshik.com/tests/51792_I93CPCGNFWD2
Evaluation of Manufacturer-Submitted Testing
This analysis shows that Injectable Anadrol 50mg contains slightly less Oxymetholone than labeled, raising concerns about consistency in dosing. As Olympian Pharmaceutical submitted and funded this test, third-party independent testing is advised to verify batch-to-batch accuracy. While Janoshik Analytical is recognized for its rigorous and transparent testing, additional validation through neutral sources would further ensure confidence in these results.
Conclusion
The findings confirm that Injectable Anadrol 50mg is slightly underdosed, with a measured concentration of 47.23 mg/ml, compared to the labeled 50 mg/ml. Although the deviation is minor, the discrepancy underscores the importance of continued testing to ensure precision in dosing. This report is provided as an educational resource to promote harm reduction and informed decision-making.
Disclaimer
This report is published for educational and harm reduction purposes. Manufacturer-submitted testing may involve inherent biases; however, it still provides useful data when critically assessed alongside third-party or independent results. Readers are encouraged to interpret this information responsibly.
